U.S. Markets closed

OxySure Therapeutics, Inc. (OXYS)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.007050.00 (0.00%)
At close: 12:17PM EDT
People also watch
PSIDPBIOSNWVPPCHNVIV
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201412/31/201312/31/2012
Total Revenue2,437.4021,800.327270.387
Cost of Revenue1,419.047592.986143.75
Gross Profit1,018.3551,207.341126.637
Operating Expenses
Research Development583.435356.01525.816
Selling General and Administrative2,469.7111,339.6241,239.009
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-2,034.791-488.298-1,138.188
Income from Continuing Operations
Total Other Income/Expenses Net188.84325.825210.407
Earnings Before Interest and Taxes-1,845.948-462.473-927.781
Interest Expense907.612249.979217.018
Income Before Tax-2,753.56-712.452-1,144.799
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-2,753.56-712.452-1,144.799
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,753.56-712.452-1,144.799
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,753.56-712.452-1,144.799